Building upon the success of last year's Stories of Women-Led Innovation Event, this forum continued highlighting the achievements and challenges faced by our women innovators and demystifying the innovation pathway through presentations and panel discussions. Sessions covered intellectual property protection, building inclusive teams and addressing bias in the context of academic innovation.
Attendees were excited to hear from our keynote speaker, Gitanjali Rao, aspiring scientist, inventor and author!
After completing his PhD at the University of Colorado Boulder, Joel led the lab buildout and assay development of a first-to-market product at a startup CRO. In his current role as the Director of Operations at Enveda Biosciences, he has overseen the development of multiple new R&D facilities.
After completing his PhD at the University of Colorado Boulder, Joel led the lab buildout and assay development of a first-to-market product at a startup CRO. In his current role as the Director of Operations at Enveda Biosciences, he has overseen the development of multiple new R&D facilities.
After completing his PhD at the University of Colorado Boulder, Joel led the lab buildout and assay development of a first-to-market product at a startup CRO. In his current role as the Director of Operations at Enveda Biosciences, he has overseen the development of multiple new R&D facilities.
After completing his PhD at the University of Colorado Boulder, Joel led the lab buildout and assay development of a first-to-market product at a startup CRO. In his current role as the Director of Operations at Enveda Biosciences, he has overseen the development of multiple new R&D facilities.
After completing his PhD at the University of Colorado Boulder, Joel led the lab buildout and assay development of a first-to-market product at a startup CRO. In his current role as the Director of Operations at Enveda Biosciences, he has overseen the development of multiple new R&D facilities.
After completing his PhD at the University of Colorado Boulder, Joel led the lab buildout and assay development of a first-to-market product at a startup CRO. In his current role as the Director of Operations at Enveda Biosciences, he has overseen the development of multiple new R&D facilities.
After completing his PhD at the University of Colorado Boulder, Joel led the lab buildout and assay development of a first-to-market product at a startup CRO. In his current role as the Director of Operations at Enveda Biosciences, he has overseen the development of multiple new R&D facilities.
This event aimed to educate and inspire entrepreneurs at all stages. Featuring panels on company formation, funding biomedical discoveries and creating strategic alliances, each session included interactive elements and the chance to network with potential partners from the Anschutz campus and beyond.
Attendees got to know Jodie Morrison, CEO of Q32 Bio, and Kimberly Muller, Executive Director of CU Innovations, through their Fireside Chat Keynote.
After completing his PhD at the University of Colorado Boulder, Joel led the lab buildout and assay development of a first-to-market product at a startup CRO. In his current role as the Director of Operations at Enveda Biosciences, he has overseen the development of multiple new R&D facilities.
After completing his PhD at the University of Colorado Boulder, Joel led the lab buildout and assay development of a first-to-market product at a startup CRO. In his current role as the Director of Operations at Enveda Biosciences, he has overseen the development of multiple new R&D facilities.
After completing his PhD at the University of Colorado Boulder, Joel led the lab buildout and assay development of a first-to-market product at a startup CRO. In his current role as the Director of Operations at Enveda Biosciences, he has overseen the development of multiple new R&D facilities.
After completing his PhD at the University of Colorado Boulder, Joel led the lab buildout and assay development of a first-to-market product at a startup CRO. In his current role as the Director of Operations at Enveda Biosciences, he has overseen the development of multiple new R&D facilities.
After completing his PhD at the University of Colorado Boulder, Joel led the lab buildout and assay development of a first-to-market product at a startup CRO. In his current role as the Director of Operations at Enveda Biosciences, he has overseen the development of multiple new R&D facilities.
After completing his PhD at the University of Colorado Boulder, Joel led the lab buildout and assay development of a first-to-market product at a startup CRO. In his current role as the Director of Operations at Enveda Biosciences, he has overseen the development of multiple new R&D facilities.
Congratulations to the judge vote winner, NowVitals pitched by Robin Deterding, MD, and the audience vote winner, Vināśa Oncology pitched by Sujatha Venkataraman, PhD!
After completing his PhD at the University of Colorado Boulder, Joel led the lab buildout and assay development of a first-to-market product at a startup CRO. In his current role as the Director of Operations at Enveda Biosciences, he has overseen the development of multiple new R&D facilities.
After completing his PhD at the University of Colorado Boulder, Joel led the lab buildout and assay development of a first-to-market product at a startup CRO. In his current role as the Director of Operations at Enveda Biosciences, he has overseen the development of multiple new R&D facilities.
With sessions featuring scientific talks, career panels, and a 2-hour networking lunch, RMBTS offered a prime platform to highlight scientific advancements and career opportunities, and foster collaboration within Colorado's scientific community.
After completing his PhD at the University of Colorado Boulder, Joel led the lab buildout and assay development of a first-to-market product at a startup CRO. In his current role as the Director of Operations at Enveda Biosciences, he has overseen the development of multiple new R&D facilities.
After completing his PhD at the University of Colorado Boulder, Joel led the lab buildout and assay development of a first-to-market product at a startup CRO. In his current role as the Director of Operations at Enveda Biosciences, he has overseen the development of multiple new R&D facilities.
After completing his PhD at the University of Colorado Boulder, Joel led the lab buildout and assay development of a first-to-market product at a startup CRO. In his current role as the Director of Operations at Enveda Biosciences, he has overseen the development of multiple new R&D facilities.
After completing his PhD at the University of Colorado Boulder, Joel led the lab buildout and assay development of a first-to-market product at a startup CRO. In his current role as the Director of Operations at Enveda Biosciences, he has overseen the development of multiple new R&D facilities.
PLATINUM SPONSORS:
SPONSORS: